Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
INVA

Market Cap: $1.52B

II

Innoviva, Inc.

INVA

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin73.09%

EBITDA Margin1.86%

EBIT Margin1.65%

Pre-tax Margin94.58%

Net Profit Margin80.56%

Earnings Yield23.55%

Valuation Multiples

Price / Book1.23

Price / Sales3.44

Price / Earnings4.24

PEG0.01

Forward PEG-0.64

EV / Sales2.76

EV / EBITDA1.49

EV / Operating Cash Flow6.39

EV / Free Cash Flow6.50

Price / Free Cash Flow8.10

Price / Operating Cash Flow7.92

Cash Flow & Capital

Free Cash Flow / Share$2.56

Operating Cash Flow / Share$2.61

Free Cash Flow Yield12.35%

Capex / Revenue0.72%

Capex / Operating Cash Flow1.66%

Capex / Depreciation0.03

Stock Compensation / Revenue5.83%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio16.01

Quick Ratio15.18

Cash Ratio12.12

Debt / Assets0.16

Debt / Capital0.18

Debt / Equity0.22

Long-Term Debt / Capital0.17

Debt / Market Cap16.95%

Net Debt / EBITDA-0.37

Solvency Ratio0.95

Financial Leverage1.38

Efficiency & Working Capital

Asset Turnover0.26

Fixed Asset Turnover35.45

Inventory Turnover3.06

Receivables Turnover4.01

Payables Turnover29.72

Days Sales Outstanding91.05

Days Inventory Outstanding119.18

Days Payables Outstanding12.28

Operating Cycle210.23

Cash Conversion Cycle197.95

Working Capital Turnover0.61

Returns & Quality

Return on Equity30.03%

Return on Assets20.98%

Return on Invested Capital8.36%

ROCE9.82%

Return on Tangible Assets23.57%

Operating Return on Assets9.19%

Income Quality0.44

Tax Burden0.85

Interest Burden0.57

Balance Sheet & Intrinsic Metrics

Enterprise Value$1.22B

Invested Capital$905.69M

Working Capital$706.3M

Tangible Asset Value$1.05B

Net Current Asset Value$283.9M

Graham Number$42.88

Graham Net-Net$2.89

Book Value / Share$16.8

Tangible Book Value / Share$14.25

Cash / Share$7.89

Financial Health Scores

Piotroski Score4

Altman Z-Score4.43

Revenue$443.43M

EBIT$733.56M

Market Cap$1.52B

Working Capital$706.3M

Retained Earnings$372.54M

Total Assets$1.7B

Total Liabilities$469.47M